Regional Covid-19 Resources and On Reserve Stats by Region Below:
Black = New Cases, Green = Recovered, Red = Deaths, Blue – Hospitalized, Purple – ISC reported total –  Updated Daily

BC
3 195 77 3,036 3,139
AB
20 484 86 8,411 8,767
SK
5 217 68 7,259 7,419
MB
38 419 87 8,223 8,539
ON
14 108 30 2,318 2,611
QC
0 14 6 735 741
Atlantic
0 0 0 22 22
North60
29 16 7 859 921
 

Widgetized Section

Go to Admin » Appearance » Widgets » and move Gabfire Widget: Social into that MastheadOverlay zone

Treatments for post-vaccine blood clots show promise but no ‘slam dunk,’ Canadian doctors say – CBC

Researchers recommend anti-clotting drugs alongside high doses of intravenous antibody-based therapy

Jun 09, 2021

Ever since health officials announced Canada’s first known case of rare, post-vaccination blood clots back in April, scientists have been racing to learn more about what causes the potentially deadly condition — and how to treat it.

Now, a team from McMaster University in Hamilton has published new research-backed recommendations calling on clinicians to use a combination of two treatments: anti-clotting drugs alongside high doses of an intravenous, antibody-based therapy.

The potential effectiveness was outlined in three case studies featuring some of the first Canadian patients who developed post-vaccine blood clots, which was published Wednesday in The New England Journal of Medicine.

The three patients between the ages of 63 and 72 were all given a dose of the AstraZeneca-Oxford COVID-19 vaccine, the paper states, and were later diagnosed with vaccine-induced immune thrombotic thrombocytopenia (VITT).

Read more: https://www.cbc.ca/news/health/post-vaccine-blood-clots-treatment-1.6059482

NationTalk Partners & Sponsors Learn More